Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1985 Oct;61(720):925–933. doi: 10.1136/pgmj.61.720.925

Drug eruptions.

S K Goolamali
PMCID: PMC2418295  PMID: 2932688

Full text

PDF
925

Images in this article

927Figure 1
on p.927
927Figure 2
on p.927
928Figure 3
on p.928
929Figure 4
on p.929
930Figure 5
on p.930
930Figure 6
on p.930

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Almeyda J., Levantine A. Drug reactions. XIX. Adverse cutaneous reactions to the penicillins--ampicillin rashes. Br J Dermatol. 1972 Sep;87(3):293–297. doi: 10.1111/j.1365-2133.1972.tb00328.x. [DOI] [PubMed] [Google Scholar]
  2. Bandmann H. J., Calnan C. D., Cronin E., Fregert S., Hjorth N., Magnusson B., Maibach H., Malten K. E., Meneghini C. L., Pirilä V. Dermatitis from applied medicaments. Arch Dermatol. 1972 Sep;106(3):335–337. [PubMed] [Google Scholar]
  3. Batchelor J. R., Welsh K. I., Tinoco R. M., Dollery C. T., Hughes G. R., Bernstein R., Ryan P., Naish P. F., Aber G. M., Bing R. F. Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility. Lancet. 1980 May 24;1(8178):1107–1109. doi: 10.1016/s0140-6736(80)91554-8. [DOI] [PubMed] [Google Scholar]
  4. Bianchine J. R., Macaraeg P. V., Jr, Lasagna L., Azarnoff D. L., Brunk S. F., Hvidberg E. F., Owen J. A., Jr Drugs as etiologic factors in the Stevens-Johnson syndrome. Am J Med. 1968 Mar;44(3):390–405. doi: 10.1016/0002-9343(68)90110-1. [DOI] [PubMed] [Google Scholar]
  5. Black A. J., Somers K. Drug-related illness resulting in hospital admission. J R Coll Physicians Lond. 1984 Jan;18(1):40–41. [PMC free article] [PubMed] [Google Scholar]
  6. Blum R. H., Carter S. K., Agre K. A clinical review of bleomycin--a new antineoplastic agent. Cancer. 1973 Apr;31(4):903–914. doi: 10.1002/1097-0142(197304)31:4<903::aid-cncr2820310422>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  7. Carroll O. M., Bryan P. A., Robinson R. J. Stevens-Johnson syndrome associated with long-acting sulfonamides. JAMA. 1966 Feb 21;195(8):691–693. [PubMed] [Google Scholar]
  8. Chandra R. K., Joglekar S. A., Tomas E. Penicillin allergy: anti-penicillin IgE antibodies and immediate hypersensitivity skin reactions employing major and minor determinants of penicillin. Arch Dis Child. 1980 Nov;55(11):857–860. doi: 10.1136/adc.55.11.857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Falkson G., Schulz E. J. Changes in hair pigmentation associated with cancer chemotherapy. Cancer Treat Rep. 1981 May-Jun;65(5-6):529–529. [PubMed] [Google Scholar]
  10. Fisher A. A. Allergic dermatitis medicamentosa: the "systemic contact-type variety". Cutis. 1976 Nov;18(5):637–642. [PubMed] [Google Scholar]
  11. Fraser T. N. Gold Treatment in Rheumatoid Arthritis. Ann Rheum Dis. 1945 Jun;4(4):71–75. doi: 10.1136/ard.4.4.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Griffin J. P. Drug-induced allergic and hypersensitivity reactions. Practitioner. 1983 Aug;227(1382):1283–1297. [PubMed] [Google Scholar]
  13. Harrison B. M., Wood C. B. Cyclophosphamide and pigmentation. Br Med J. 1972 May 6;2(5809):352–352. doi: 10.1136/bmj.2.5809.352-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Harrold B. P. Syndrome resembling Addison's disease following prolonged treatment with busulphan. Br Med J. 1966 Feb 19;1(5485):463–464. doi: 10.1136/bmj.1.5485.463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Horio T. Photoallergic reaction. Classification and pathogenesis. Int J Dermatol. 1984 Jul-Aug;23(6):376–382. doi: 10.1111/j.1365-4362.1984.tb03195.x. [DOI] [PubMed] [Google Scholar]
  16. Huff J. C., Weston W. L., Tonnesen M. G. Erythema multiforme: a critical review of characteristics, diagnostic criteria, and causes. J Am Acad Dermatol. 1983 Jun;8(6):763–775. doi: 10.1016/s0190-9622(83)80003-6. [DOI] [PubMed] [Google Scholar]
  17. Kauppinen K., Stubb S. Drug eruptions: causative agents and clinical types. A series of in-patients during a 10-year period. Acta Derm Venereol. 1984;64(4):320–324. [PubMed] [Google Scholar]
  18. Kennedy B. J., Smith L. R., Goltz R. W. Skin changes secondary to hydroxyurea therapy. Arch Dermatol. 1975 Feb;111(2):183–187. [PubMed] [Google Scholar]
  19. Klinefelter Reinstitution of gold therapy in rheumatoid arthritis after mucocutaneous reactions. J Rheumatol. 1975 Mar;2(1):21–27. [PubMed] [Google Scholar]
  20. Korkij W., Soltani K. Fixed drug eruption. A brief review. Arch Dermatol. 1984 Apr;120(4):520–524. [PubMed] [Google Scholar]
  21. Kuokkanen K. Drug eruptions. A series of 464 cases in the Department of Dermatology, University of Turku, Finland, during 1966-1970. Acta Allergol. 1972 Dec;27(5):407–438. [PubMed] [Google Scholar]
  22. Levantine A., Almeyda J. Drug induced changes in pigmentation. Br J Dermatol. 1973 Jul;89(1):105–112. doi: 10.1111/j.1365-2133.1973.tb01932.x. [DOI] [PubMed] [Google Scholar]
  23. Leyden J. J., Kligman A. M. Contact dermatitis to neomycin sulfate. JAMA. 1979 Sep 21;242(12):1276–1278. [PubMed] [Google Scholar]
  24. McGrae J. D., Jr, Zelickson A. S. Skin pigmentation secondary to minocycline therapy. Arch Dermatol. 1980 Nov;116(11):1262–1265. [PubMed] [Google Scholar]
  25. Papadopoulos S., Harden R. M. Hair loss in patients treated with carbimazole. Br Med J. 1966 Dec 17;2(5528):1502–1503. doi: 10.1136/bmj.2.5528.1502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Penneys N. S., Ackerman A. B., Gottlieb N. L. Gold dermatitis. A clinical and histopathological study. Arch Dermatol. 1974 Mar;109(3):372–376. doi: 10.1001/archderm.109.3.372. [DOI] [PubMed] [Google Scholar]
  27. Petz L. D., Fudenberg H. H. Coombs-positive hemolytic anemia caused by penicillin administration. N Engl J Med. 1966 Jan 27;274(4):171–178. doi: 10.1056/NEJM196601272740401. [DOI] [PubMed] [Google Scholar]
  28. Resnik S. Melasma induced by oral contraceptive drugs. JAMA. 1967 Feb 27;199(9):601–605. [PubMed] [Google Scholar]
  29. Ros A. M., Juhlin L., Michaëlsson G. A follow-up study of patients with recurrent urticaria and hypersensitivity to aspirin, benzoates and azo dyes. Br J Dermatol. 1976 Jul;95(1):19–24. doi: 10.1111/j.1365-2133.1976.tb15532.x. [DOI] [PubMed] [Google Scholar]
  30. Satanove A. Pigmentation due to phenothiazines in high and prolonged dosage. JAMA. 1965 Jan 25;191(4):263–268. [PubMed] [Google Scholar]
  31. Shah P. C., Rao K. R., Patel A. R. Cyclophosphamide induced nail pigmentation. Br J Dermatol. 1978 Jun;98(6):675–680. doi: 10.1111/j.1365-2133.1978.tb03587.x. [DOI] [PubMed] [Google Scholar]
  32. Shapiro S., Siskind V., Slone D., Lewis G. P., Jick H. Drug rash with ampicillin and other penicillins. Lancet. 1969 Nov 8;2(7628):969–972. doi: 10.1016/s0140-6736(69)90535-2. [DOI] [PubMed] [Google Scholar]
  33. Simons J. J., Morales A. Minocycline and generalized cutaneous pigmentation. J Am Acad Dermatol. 1980 Sep;3(3):244–247. doi: 10.1016/s0190-9622(80)80186-1. [DOI] [PubMed] [Google Scholar]
  34. Speer F., Denison T. R., Baptist J. E. Aspirin allergy. Ann Allergy. 1981 Mar;46(3):123–126. [PubMed] [Google Scholar]
  35. Stubb S. Blood leukocytes, with special reference to basophils and eosinophils, during provocation tests in fixed eruption and drug exanthema. Acta Derm Venereol Suppl (Stockh) 1976;56(76):1–47. [PubMed] [Google Scholar]
  36. Wannamaker L. W. A penicillin shot without culturing the child's throat. JAMA. 1976 Mar 1;235(9):913–914. [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES